The maker of Marlboro cigarettes is gaining a ‘unique entry into cannabis’ (MO, CRON)

marlboro phillip morris altriaAP

  • Altria‘s $ 1.8 billion investment in the cannabis producer Cronos is mutually beneficial, a Cowen analyst says.
  • Cronos has a focus on rare cannabinoids, which has greater potential than just focusing on the two most known cannabinoids, Azer added.
  • Cronos can leverage Altria’s expertise to focus on ingredient composition without reliance on a massive cultivation infrastructure, Azer said.
  • Watch Altria and Cronos trade live.

Marlboro cigarette maker Altria‘s $ 1.8 billion investment in the cannabis producer Cronos is a win-win, according to an analyst.

“Cronos provides Altria a unique entry into cannabis and we do not think Altria is taking on outsized risk while entering a new high-growth category,” Vivien Azer, an analyst at Cowen, said in a note out on Monday.

See the rest of the story at Business Insider

NOW WATCH: 7 things you shouldn’t buy on Black Friday

See Also:

Post Author: martin

Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.